Authors
The Canadian financial sector has evolved rapidly in recent years as financial services move online and regulated financial institutions increasingly compete with businesses outside the federal regulatory framework. In response to concerns from stakeholders that current statutory limitations prevent or complicate investments by federally regulated financial institutions (FRFIs) in fintech firms, and restrict their ability to leverage technology and other commercial activities in-house (each of which may hamper their ability to innovate and serve the needs of Canadian consumers), legislative amendments (the NFA Amendments) were made to the Bank Act, Trust and Loan Companies Act and Insurance Companies Act (the FRFI Statutes) as part of Budget Implementation Act, 2018, No. 1. These amendments were meant to provide greater flexibility for FRFIs to undertake certain non-financial activities and to invest in financial technology companies that offer services beyond traditional financial services. However, almost a decade later, the NFA Amendments have not been brought into force, awaiting the adoption of regulations necessary to establish the terms and conditions required to implement those new provisions.
On October 17, the long-awaited Non-Financial Activities (Banks and Bank Holding Companies) Regulations, together with substantively similar regulations governing foreign banks, trust and loan companies, and insurance companies (collectively, the Proposed Regulations), were published in the Canada Gazette for comment, paving the way for operationalization of the NFA Amendments—hopefully in early 2027.
The Proposed Regulations were drafted to ensure that the NFA Amendments are used in a measured and incremental way, potential risks are understood and mitigated over time, and key principles of the financial sector legislative framework, such as ensuring that FRFIs remain primarily oriented towards financial services, are maintained.
The federal government has long imposed restrictions on commercial activities, dating back to the first Bank Act in 1871. While the FRFI Statutes have been amended over time to permit specific non-financial technology or information processing activities in limited circumstances and with Minister of Finance approval, FRFIs generally remain restricted from engaging in, or investing in entities that engage in, activities other than the business of providing financial services.
The federal government introduced several significant amendments in the 2018 Budget Implementation Act to provide greater flexibility for FRFIs to undertake non-financial activities, as defined below in the Proposed Regulations (NFAs). Specific amendments included:
See our earlier bulletins, Budget 2018’s Impact on the Canadian Financial Sector and Significant Change Ahead for Financial Institution Statutes, for further discussion on the NFA Amendments.
Rather than introducing narrow powers that could be used without limit, the federal government has opted for the broader powers described above paired with quantitative limits, along with a regulatory line of sight into the new activities. Accordingly, the Proposed Regulations establish (i) limits and conditions on a FRFI’s use of the expanded business and investment powers to ensure FRFIs remain primarily oriented towards financial services; and (ii) reporting requirements that ensure the Department of Finance has sufficient information to evaluate the policy outcomes and effectiveness of the business power expansion over time.
Once the NFA Amendments are brought into force, there would be three avenues through which FRFIs may engage in NFAs without prior ministerial approval: (1) directly through business powers contemplated in the FRFI Statutes; (2) through investments in an MFSE; and (3) through an investment in another FRFI or other permitted investment entity that engages in at least one permitted NFA (an entity engaging in non-financial activities, or EENFA).
The Proposed Regulations create a definition of NFA by reference to the updated business powers in the FRFI Statutes related to information processing, dealing in information technology, and activities related to providing financial services, and define “majority” for purposes of the newly created MFSE as at least 60% of annual revenue, operating expenses or assets of the entity attributable to financial service activities1. This metric would be measured on a quarterly basis against the four most recent quarterly financial statements, or if quarterly financial statements are not prepared, the most recent annual financial statement. From a practical standpoint, these calculations may prove challenging, as many early-stage fintechs generate little revenue and hold mainly intangible assets.
The Proposed Regulations impose two main conditions that FRFIs must meet in order to engage directly in NFAs or invest in an EENFA or MFSE, which will vary depending on the size of the FRFI.
The first condition would limit the extent to which an FRFI’s business may be oriented toward NFAs by ensuring that the aggregate annual revenues attributable to NFAs (either directly or through a EENFA or MFSE subsidiary) do not exceed a specified percentage of its total annual revenues.
The second condition is designed to limit the aggregate exposure of an FRFI to MFSEs and EENFAs. Under this requirement, the aggregate value of ownership interests, loans, and guarantees relating to MFSEs and NFAs that the FRFI controls or has a substantial investment in could not exceed a specified percentage of the FRFI’s total regulatory capital.
In general, large FRFIs (with equity of $12 billion or more) would be subject to a 10% limit under both the revenue-based and regulatory capital-based tests. FRFIs with equity less than $12 billion would also be subject to a 10% regulatory capital limit, but with a higher revenue limit of 15%2.
If an FRFI breaches either the revenue-based or regulatory capital-based limit while holding control of, or a substantial investment in, an EENFA or MFSE, all of the FRFI’s investments in such entities would be automatically deemed as “temporary investments”, and the FRFI would have two years to satisfy the conditions of the Proposed Regulations or move the investments into a permitted investment category.
Prior to engaging in NFA business, the FRFI would be required to develop a methodology for categorizing and attributing NFA business revenue and capital exposure. Large FRFIs would be required to provide the Department of Finance with a description of this methodology on an annual basis.
In addition, large FRFIs would be subject to ongoing reporting obligations, but small and medium-sized FRFIs would be exempt (which is welcome news for them, as this could have been a significant burden for smaller institutions that may not have the resources available to dedicate to such reporting). In practice, we are also unsure how these reporting requirements will play out with the larger FRFIs, as the burdensome obligations may encourage fintechs to avoid relationships with banks to protect confidential information. Specifically, for the larger FRFIs, a transaction report would also be required no later than 30 days following the completion of any controlling or non-controlling substantial investment in a EENFA or a MFSE (the reporting requirements will be more onerous in respect of controlling investments) and an annual report would be required no later than six months after any financial year in which the FRFI engages in NFAs or invests in an EENFA or a MFSE.
Notwithstanding the reporting obligations above in respect of NFA activity and investments in MFSEs and EENFAs, we were pleased to note that the Proposed Regulations did not impose any further requirements or expectations on the expanded networking powers that will be adopted as part of the NFA Amendments. In our view, there are already mitigants in place (e.g., reputational, privacy, consumer protection) to ensure that FRFIs do not inappropriately use this power and therefore we were pleased to note that additional constraints were not imposed under the Proposed Regulations.
The FRFI Statutes currently permit FRFIs to undertake a limited set of information technology and processing activities with approval from the Minister of Finance. Therefore the Proposed Regulations would not apply to activities for which the Minister of Finance has previously granted approval (the rationale being that the Department of Finance would already have a line of sight into the business as part of the original approval). However, if that business were to change or evolve outside of what was previously approved, the FRFI would be required to apply the conditions of the Proposed Regulations to the unapproved portion of the business, including tracking, measuring, and reporting on it against the proportional limits.
We note that the Proposed Regulations refer to the current sections of the FRFI Statutes that permit these activities, but not to any predecessor sections from earlier versions of the FRFI Statutes under which a Minister of Finance approval may have been obtained. It would be helpful if the Proposed Regulations were more explicit, but we believe that the Regulatory Impact Analysis Statement makes it clear that if a Minister of Finance approval has previously been granted in respect of an activity or investment, the Proposed Regulations would not apply.
The Proposed Regulations also carry forward exemptions from the Information Processing Activities (Banks and Authorized Foreign Banks) Regulations, which include, among other things, classifying and reporting payments, and preparing an employer’s payroll. These activities would not be subject to the conditions and limits in the Proposed Regulations as they are not considered by the Department of Finance to be the type of non-financial commercial technology or activity that merits additional regulatory scrutiny.
The Proposed Regulations also include transitional provisions for certain information technology and processing activities or investments that do not currently require approval from the Minister of Finance. These include collecting, processing, and transmitting information outside of Canada, as well as investments in entities whose business is limited to developing, designing, holding, managing, manufacturing, selling, or otherwise dealing with any data transmission system, information site, communication device or information platform or portal that is used to provide information services (as prescribed in the Information Technology Activities Regulations under each FRFI Statute).
Since these activities that are carried out today would become NFA business, they would be subject to the conditions and limits included in the Proposed Regulations; however, the Department of Finance acknowledges the challenge with complying with the Proposed Regulations on Day 1 and therefore a two-year transition period was included.
The Proposed Regulations are open for comment until November 16. While they would provide a transition period of two years for certain existing permitted NFA activities, large FRFIs subject to the reporting obligations should begin assessing their existing technology activities and investments, developing limit-calculation methodologies, and preparing compliance functions for the proposed requirements.
Le mois dernier, le Canada a publié sa première Stratégie industrielle de défense (la Stratégie), qui souligne l’engagement du Canada à développer une base industrielle de défense solide et à stimuler la croissance économique. Ces efforts pourraient aussi comprendre le renforcement de l’état de préparation à la biodéfense et aux contre-mesures médicales, ce qui pourrait constituer des débouchés pour le secteur canadien des sciences de la vie en raison de l’importance accordée aux capacités nationales en ce sens et de la nécessité d’atténuer les risques d’urgences sanitaires.
Comme indiqué dans les bulletins précédents, le quatrième pilier de la Stratégie est axé sur la « sécurisation des chaînes d’approvisionnement pour les intrants et les biens clés » par le renforcement de la production nationale et le stockage de ressources. L’accent est mis tout particulièrement sur les contre-mesures médicales, en précisant que nos « alliés ont établi un lien explicite entre l’état de préparation à la biodéfense et aux contre-mesures médicales et leur sécurité économique et nationale, en élaborant de nouvelles stratégies et de nouveaux mécanismes pour faire progresser ces travaux ». Les contre-mesures médicales désignent divers produits réglementés pouvant être utilisés pour protéger la population lors d’une situation d’urgence de grande ampleur, comme l’éclosion d’une maladie ou une attaque impliquant des armes chimiques, biologiques ou nucléaires. Il peut s’agir de vaccins, de médicaments thérapeutiques et produits biologiques, de dispositifs de tests diagnostiques, des équipements de protection individuelle ou industrielle, et d’autres dispositifs médicaux. Les contre-mesures médicales sont essentielles à la réduction et à l’atténuation des dommages lors d’une urgence de santé publique.
Pendant et après la pandémie de COVID-19, le Canada a mis en place plusieurs nouvelles voies réglementaires comme mécanismes d’accélération des approbations de produits médicaux, ce qui pourrait offrir au gouvernement des options pour déployer des contre-mesures médicales afin de faire face aux risques pour la santé publique. Au début de la pandémie, Santé Canada a émis diverses ordonnances provisoires pour permettre l’importation et la vente de médicaments et de dispositifs médicaux qui n’avaient pas eu l’approbation des voies réglementaires traditionnelles. Or, Santé Canada a plutôt fait confiance aux voies d’approbation réglementaire et de l’exemption de certaines exigences en homologation de produits des pays impliqués dans la transaction. Beaucoup de ces règles provisoires ont depuis été officiellement intégrées à la réglementation en vertu de la Loi sur les aliments et drogues et ont été appliquées bien après la COVID-19. Conformément au Règlement sur les aliments et drogues, Santé Canada tient à jour la Liste des maladies qui menacent la santé publique et utilisera une procédure d’autorisation modifiée pour les médicaments d’urgence de santé publique pouvant traiter les affections figurant sur la liste. De même, le Règlement sur les instruments médicaux a établi une liste d’instruments médicaux répondant à un besoin urgent de santé publique, ce qui permet à Santé Canada d’autoriser la commercialisation de ces instruments de manière accélérée. Ces outils réglementaires sont utilisés automatiquement quand une situation médicale présente un grand risque pour la santé publique au Canada et nécessite une action immédiate pour contrer ce risque.
La stratégie prévoit que le Canada adoptera une approche proactive en matière de planification en amont des crises sanitaires. Le gouvernement entend s’assurer que les produits médicaux sont déjà disponibles au Canada afin qu’ils puissent être distribués rapidement en cas d’urgence. D’autres modifications récentes au Règlement sur les aliments et drogues permettent de prépositionner au Canada tous les médicaments d’urgence en santé publique, ce qui signifie qu’ils peuvent être importés dans des installations d’entreposage canadiennes avant que leur mise sur le marché n’ait été autorisée. La Stratégie s’appuie sur ces fondements, en faisant référence à l’organisme existant Préparation aux crises sanitaires Canada (PCSC), un organisme opérationnel spécial au sein d’Innovation, Sciences et Développement économique Canada (ISDE), et à un nouveau Fonds des sciences de la vie, lesquels « collaborent avec des partenaires internationaux et de soutenir l’élaboration et la production de contre-mesures médicales ». PCSC supervise la Stratégie en matière de biofabrication et de sciences de la vie du Canada, qui vise à développer un secteur national des sciences de la vie fort et compétitif doté de capacités de biofabrication de pointe, en mettant l’accent sur la capacité à se préparer et à faire face aux futures priorités et crises sanitaires. Dans cette optique, il y aura des occasions pour les fabricants de nouer des collaborations de recherche et des accords commerciaux ou d’approvisionnement liés aux contre-mesures médicales financées par des programmes fédéraux.
Étroitement lié aux capacités nationales, le pilier III de la stratégie implique « Investissement ciblé pour renforcer un secteur canadien de la défense novateur », avec la promesse que le gouvernement fédéral « soutiendr[a] la recherche et le développement, protéger[a] la propriété intellectuelle, soutiendr[a] les petites et moyennes entreprises, investir[a] dans les compétences et la formation, et encourager[a] les exportations afin de créer un secteur de la défense agile et concurrentiel à l’échelle mondiale ». La nécessité de favoriser le développement de la propriété intellectuelle (PI) et la conservation des droits du Canada est mentionnée à plusieurs reprises dans la Stratégie. Par exemple, la Stratégie prévoit l’établissement de partenariats officiels avec l’industrie canadienne qui « [assureront] la propriété et le contrôle nationaux de la propriété intellectuelle (PI) et des capacités essentielles. » La Stratégie reconnaît l’immense talent des établissements canadiens et la précieuse recherche qui y est menée actuellement et qui est déjà financée par des subventions de recherche d’organismes tels que le Conseil de recherches en sciences naturelles et en génie et les Instituts de recherche en santé du Canada, et fait aussi référence à l’engagement de 1,6 milliard de dollars pour de nouveaux fonds de recherche dans le budget de 2025. Cette prise de conscience de la nécessité de promouvoir et de soutenir l’innovation au Canada laisse présager des possibilités de financement, notamment dans les domaines où le Canada accuse un retard en matière de production nationale et où des engagements d’investissement et de fabrication au Canada peuvent être pris.
Dans les prochains mois, nous prévoyons que le gouvernement du Canada publiera d’autres directives et des mesures de suivi. L’équipe de défense des conservateurs poursuivra sa couverture de perspectives sur la défense au Canada en publiant une analyse supplémentaire pour donner des précisions sur l’incidence de la Stratégie sur de multiples secteurs.